RENIER J BRENTJENS, MD
Osteopathic Medicine at York Ave, New York, NY
License number
New York 209957
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1275 York Ave, New York, NY 10021
Phone
(646) 227-3813
Personal information
See more information about RENIER J BRENTJENS at radaris.comName
Address
Phone
303 60Th St, New York, NY 10022
Professional information
Physician At Mskcc
Position:
Physician at MSKCC
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
MSKCC
-
Physician
Dr. Renier Brentjens, New York NY - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
MEMORIAL HEMATOLOGY LYMPHOMA GROUP
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
1275 York Ave, New York 10065
(800) 525-2225 (Phone)
Certifications:
Internal Medicine, 1999, Medical Oncology, 2002
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
MEMORIAL HEMATOLOGY LYMPHOMA GROUP
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Education:
Medical School
University At Buffalo State University Of New York School Of Medicine
Graduated: 1996
Yale New Haven Hospital
Memorial Sloan-Kettering Cancer Center
University At Buffalo State University Of New York School Of Medicine
Graduated: 1996
Yale New Haven Hospital
Memorial Sloan-Kettering Cancer Center
Renier J Brentjens, New York NY
Specialties:
Internal Medicine, Hematology & Oncology, Medical Oncology, Clinical Pathology/Laboratory Medicine
Work:
Memorial Sloan-Kettering
1275 York Ave, New York, NY 10065
1275 York Ave, New York, NY 10065
Education:
State University of New York at Buffalo (1996)
Renier J Brentjens, New York NY
Specialties:
Internist
Address:
1275 York Ave, New York, NY 10065
633 3Rd Ave, New York, NY 10017
633 3Rd Ave, New York, NY 10017
Education:
State University of New York, School of Medicine and Biomedical Sciences (Buffalo) - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Residency - Internal Medicine
Yale New Haven Psychiatric Hospital - Residency - Internal Medicine
Chimeric T Cell Receotors
US Patent:
2004004, Mar 4, 2004
Filed:
May 28, 2003
Appl. No.:
10/448256
Inventors:
Michel Sadelain - New York NY, US
Renier Brentjens - New York NY, US
John Maher - London, GB
Renier Brentjens - New York NY, US
John Maher - London, GB
Assignee:
Sloan Kettering Institute for Cancer Research - New York NY
International Classification:
C12Q001/68, C07H021/04, C12P021/02, C12N005/06, C07K014/705, C07K016/28
US Classification:
435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 530/388220, 536/023500
Abstract:
Chimeric T cell receptors (TCR) are provided that combine, in a single chimeric species, the intracellular domain of CD3 -chain, a signaling region from a costimulatory protein such as CD28, and a binding element that specifically interacts with a selected target. When expressed, for example in T-lymphocytes from the individual to be treated for a condition associated with the selected target, a T cell immune response is stimulated in the individual to the target cells. The chimeric TCR's are able to provide both the activation and the co-stimulation signals from a single molecule to more effectively direct T-lymphocyte cytotoxicity against the selected target and T-lymphocyte proliferation.